27 min listen
Interview with Cala Health’s CCO Doug Biehn about Neuromodulation Therapy Cala Trio for Hand Tremors
Interview with Cala Health’s CCO Doug Biehn about Neuromodulation Therapy Cala Trio for Hand Tremors
ratings:
Length:
20 minutes
Released:
Mar 1, 2023
Format:
Podcast episode
Description
In this week’s Xtalks Life Science podcast episode, Sarah spoke with Doug Biehn, Chief Commercial Officer at Cala Health, a bioelectronic medicine company that develops wearable neuromodulation therapies.The company’s lead product, Cala Trio, was approved by the US Food and Drug Administration (FDA) in 2018 for transient relief of hand tremors in adults with essential tremor (ET).Tune into the episode to learn more about Cala Health’s individualized prescription neuromodulation therapy. Doug discussed the day-to-day struggles of patients with ET and the challenges they face when seeking medication for their condition. Doug also shared the benefits of Cala Trio for the relief of hand tremors and how company is committed to ensuring all patients have access to this life-changing neuromodulation therapy.For more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @XtalksInstagram: @XtalksFacebook: https://www.facebook.com/Xtalks.Webinars/LinkedIn: https://www.linkedin.com/company/xtalks-webconferencesYouTube: https://www.youtube.com/c/XtalksWebinars/featured
Released:
Mar 1, 2023
Format:
Podcast episode
Titles in the series (100)
Social Media’s Disinformation Dozen + Pfizer’s Latest COVID-19 Vaccine Trial Results by Xtalks Life Science Podcast